A single nucleotide polymorphism in cBIM is associated with a slower achievement of major molecular response in chronic myeloid leukaemia treated with imatinib.

by Vanessa Augis, Kelly Airiau, Marina Josselin, Béatrice Turcq, François-Xavier Mahon, Francis Belloc
Published 2013-01-01